Riken Pharmaceuticals Private Limited
About Riken Pharmaceuticals Private Limited
Data last updated:
Riken Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 23 November 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24290DL2013PTC260824. Its GSTIN is 09AAGCR7580P1ZF (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Gyan Prakash Tiwari and Nisha Tiwari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 4649/147 – E Modern Shahdara, Delhi, India – 110032.
As per the financials filed for FY 2025, the company reported a revenue of ₹47.58 Lakh, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹2.08 Lakh (net margin 4.4%) and EBITDA of ₹3.56 Lakh (EBITDA margin 7.5%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 18% over five years.
As per MCA filings, the company has open charges of ₹8 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Riken Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address4649/147 – E Modern Shahdara, Delhi, India – 110032
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Riken Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Riken Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Riken Pharmaceuticals Private Limited, buy the company report.
Financials of Riken Pharmaceuticals Private Limited
FY 2025 filings availableRiken Pharmaceuticals Private Limited reported revenue of ₹47.58 Lakh (up 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 8% growth in the latest year. EBITDA rose 101% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.56 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.08 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.5% | ||||
| Net Profit Margin | 4.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Riken Pharmaceuticals Private Limited, buy the company report.
Board of directors of Riken Pharmaceuticals Private Limited
Riken Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gyan Prakash Tiwari | Director | 23 Nov 2013 | 12 Years 11 Months | Current |
| Nisha Tiwari | Director | 23 Nov 2013 | 12 Years 11 Months | Current |
Peer comparison
Riken Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Med Mines Pharmaceuticals Private Limited | ₹47.6 Lakh (FY 2024) | 18.0% | Kanpur, Uttar Pradesh, India | |||
| Riken Pharmaceuticals Private Limitedthis company | ₹47.58 Lakh (FY 2025) | ₹2.08 Lakh | 4.4% | 8.0% | Delhi, India | |
| Bharatam Jayate Pharmacy Private Limited | ₹47.57 Lakh (FY 2024) | 23267.0% | Chandigarh, India | |||
| Covet Biotech Private Limited | ₹47.46 Lakh (FY 2024) | 71.0% | Jaipur, Rajasthan, India | |||
| Growmed Lifesciences Private Limited | ₹47.37 Lakh (FY 2024) | 9.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Riken Pharmaceuticals Private Limited, buy the company report.
Auditor
Riken Pharmaceuticals Private Limited is audited by AMIT V GUPTA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AMIT V GUPTA & ASSOCIATES | FY 2023 | 018333N |
Shareholding
The shareholding of Riken Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Riken Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 Dec 2019 | 100308315 | Others | ₹8 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Riken Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Riken Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Riken Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAGCR7580P1ZF | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Riken Pharmaceuticals Private Limited, buy the company report.
Recent activity
Riken Pharmaceuticals Private Limited has 2 board changes on record since 2013: 2 appointments. The latest: Gyan Prakash Tiwari was appointed as Director on 23 Nov 2013.
Frequently asked questions
Riken Pharmaceuticals is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 23 November 2013 (13+ years old) and is registered under CIN U24290DL2013PTC260824.
Riken Pharmaceuticals has 2 current directors:
- Gyan Prakash Tiwari - Director
- Nisha Tiwari - Director
The latest financial statements of Riken Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Riken Pharmaceuticals is 09AAGCR7580P1ZF, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Riken Pharmaceuticals is U24290DL2013PTC260824. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Riken Pharmaceuticals was incorporated on 23 November 2013, making it 13+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Riken Pharmaceuticals by revenue are Med Mines Pharmaceuticals Private Limited, Bharatam Jayate Pharmacy Private Limited, Covet Biotech Private Limited, Growmed Lifesciences Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Gyan Prakash Tiwari was appointed as Director on 23 Nov 2013. Nisha Tiwari was appointed as Director on 23 Nov 2013.
The registered office of Riken Pharmaceuticals is at 4649147 – E Modern Shahdara, Delhi, India – 110032.
Riken Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Riken Pharmaceuticals has open charges of ₹8 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
